APVO442 Prostate Cancer Data Presented at the American Association for Cancer Research Annual Meeting

Author's Avatar
Apr 12, 2022

Preclinical Data Support Potential for APVO442 in Difficult-to-Treat Types of Prostate Cancer, Including Metastatic Castration-Resistant Disease